Touyun Biotech Group Limited

SEHK:1332 Rapport sur les actions

Capitalisation boursière : HK$477.0m

Touyun Biotech Group Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Amy Ha

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général2.8yrs
Propriété du PDGn/a
Durée moyenne d'occupation des postes de direction5.3yrs
Durée moyenne du mandat des membres du conseil d'administration7.9yrs

Mises à jour récentes de la gestion

Recent updates

Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%

Sep 15
Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%

Touyun Biotech Group Limited's (HKG:1332) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jul 17
Touyun Biotech Group Limited's (HKG:1332) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 28%

Apr 22
Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 28%

Would Touyun Biotech Group (HKG:1332) Be Better Off With Less Debt?

Apr 08
Would Touyun Biotech Group (HKG:1332) Be Better Off With Less Debt?

What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You

Feb 07
What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You

Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding

Dec 18
Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding

Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt

Sep 19
Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt

Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)

Jul 28
Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Sep 13
Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

May 18
Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Dec 24
Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?

Mar 12
Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?

If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns

Jan 15
If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns

The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares

Jan 15
The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares

How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?

Dec 11
How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?

PDG

Amy Ha (52 yo)

2.8yrs

Titularisation

Ms. Amy Ha (Former name: Ha Man) is Chief Executive Officer of Touyun Biotech Group Limited from January 03, 2022. She has extensive experiences in the financial management and investment. From April 1998...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Liang Wang
Executive Chairman8.2yrsHK$3.60m27.35%
HK$ 130.5m
Dong Du
Executive Director7.9yrsHK$1.22mpas de données
Amy Ha
Chief Executive Officer2.8yrspas de donnéespas de données
On Lok Li
Company Secretary2.3yrspas de donnéespas de données

5.3yrs

Durée moyenne de l'emploi

41.5yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de 1332 est chevronnée et expérimentée (5.3 années d'ancienneté moyenne).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Liang Wang
Executive Chairman8.2yrsHK$3.60m27.35%
HK$ 130.5m
Dong Du
Executive Director7.9yrsHK$1.22mpas de données
Shing Chuen To
Independent Non-Executive Director10yrsHK$248.00kpas de données
Kee Choy Ha
Independent Non-Executive Director10yrsHK$248.00kpas de données
Wing Ping Cheung
Independent Non-Executive Director9.3yrsHK$248.00kpas de données
Hui Chen
Non-Executive Director7.9yrsHK$240.00kpas de données
Guohua Hu
Independent Non-Executive Director4yrsHK$100.00kpas de données
Yuze Tian
Non-Executive Director4.6yrsHK$120.00k5.2%
HK$ 24.8m
Lele Zhang
Non-Executive Director4yrsHK$978.00kpas de données
Wenjie Jia
Non-Executive Director4yrsHK$20.00k0.036%
HK$ 170.0k

7.9yrs

Durée moyenne de l'emploi

44.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 1332 sont considérés comme expérimentés (ancienneté moyenne 7.9 ans).